ExodusPoint Capital Management’s Larimar Therapeutics LRMR Stock Holding History

ExodusPoint Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$119K	Sell	26,445 -317,801	-92%	-$1.27M	﹤0.01%	1427
2025 Q4	$1.31M	Buy	344,246 +181,425	+111%	+$706K	0.01%	896
2025 Q3	$526K	Buy	+162,821	New	+$611K	0.01%	1168
2024 Q4	–	Sell	-21,119	Closed	-$138K	–	1812
2024 Q3	$138K	Buy	+21,119	New	+$170K	﹤0.01%	1492
2021 Q2	–	Sell	-36,632	Closed	-$535K	–	2610
2021 Q1	$535K	Sell	36,632 -22,774	-38%	-$414K	0.01%	1296
2020 Q4	$1.27M	Buy	+59,406	New	+$1.19M	0.01%	734

Other funds holding LRMR

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return